|
| 1 |
Glasgow prognostic score and combined positive score for locally advanced rectal cancer
Yanru Feng, Jialin Luo, Peng Liu, Luying Liu, Yuan Zhu, Guoping Cheng, Linfeng Zheng
|
|
| 2 |
Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non–Small Cell Lung Cancer
Hyun-Seock Shin, Juwhan Choi, Jinhwan Lee, Sung Yong Lee
Cancer Res Treat.2022;54(2):458-468. Published online 2021 September 10
DOI: http://dx.doi.org/10.4143/crt.2021.425
|
|
| 3 |
Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients
Jee Hee Yoon, Min-ho Shin, Hee Nam Kim, Wonsuk Choi, Ji Yong Park, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
|
|
| 4 |
Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors
Jee Hee Yoon, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
Endocrinol Metab.2021;36(2):413-423. Published online 2021 April 6
DOI: http://dx.doi.org/10.3803/EnM.2020.906
|
|
| 5 |
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery
Min Ho Lee, Kyung-Rae Cho, Jung Won Choi, Doo-Sik Kong, Ho Jun Seol, Do-Hyun Nam, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jung-Il Lee
|
|
| 6 |
Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Juwhan Choi, Sung Yong Lee
Immune Netw.2020;20(1):e9. Published online 2020 February 17
DOI: http://dx.doi.org/10.4110/in.2020.20.e9
|
|
| 7 |
Peripheral blood immune cell-based biomarkers in anti-PD-1/PD-L1 therapy
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin
Immune Netw.2020;20(1):e8. Published online 2020 February 10
DOI: http://dx.doi.org/10.4110/in.2020.20.e8
|
|
| 8 |
Peripheral Blood Immune Cell-based Biomarkers in Anti-PD-1/PD-L1 Therapy
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin
Immune Netw.2020;20(1):e8. Published online 2020 February 4
DOI: http://dx.doi.org/10.4110/in.2020.20.e8
|
|
| 9 |
Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Juwhan Choi, Sung Yong Lee
Immune Netw.2020;20(1):e9. Published online 2020 February 4
DOI: http://dx.doi.org/10.4110/in.2020.20.e9
|
|
| 10 |
Prognostic Value of Combined Programmed Cell Death 1 Ligand and p16 Expression Predicting Responsiveness to Radiotherapy in Patients with Oropharyngeal Squamous Cell Carcinoma
Minsu Kwon, Dae Hwan Kim, Ki Ju Cho, Youngchul Kim, Jin Pyeong Kim, Bae Kwon Jeong, Jong Sil Lee, Ji-Hyun Seo, Jung Je Park
|
|
| 11 |
Natural Killer Cells and Thyroid Diseases
Eun Kyung Lee, John B. Sunwoo
|
|
| 12 |
Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer
Xinxin Zhu, Jinghe Lang
|
|
| 13 |
Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer
Jong Ho Cho, Wei Zhou, Yoon-La Choi, Jong-Mu Sun, Hyejoo Choi, Tae-Eun Kim, Marisa Dolled-Filhart, Kenneth Emancipator, Mary Anne Rutkowski, Jhingook Kim
Cancer Res Treat.2018;50(1):95-102. Published online 2017 March 17
DOI: http://dx.doi.org/10.4143/crt.2016.591
|
|
| 14 |
PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients
Jiheun Han, Yongkil Hong, Youn Soo Lee
|
|
| 15 |
Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
Hae Il Jung, Dongjun Jeong, Sanghee Ji, Tae Sung Ahn, Sang Ho Bae, Susie Chin, Jun Chul Chung, Hyung Chul Kim, Moon Soo Lee, Moo-Jun Baek
|
|
